Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen. (Q45855994)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

title

Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

Johanna G van der Bom

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

author name string

J Astermark

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

R Ljung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

E Berntorp

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

D E Grobbee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

H M van den Berg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

753-760

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

The changing patterns of factor VIII (FVIII) and factor IX (FIX) clotting factor usage in a comprehensive care centre between 1980 and 1994.

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Resource utilisation in haemophiliacs treated in Europe: results from the European Study on Socioeconomic Aspects of Haemophilia Care. The European Socioeconomic Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Confounding and indication for treatment in evaluation of drug treatment for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Joint evaluation instruments for children and adults with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

Improved cost-effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

MRI findings in haemophilic joints treated with radiosynoviorthesis with development of an MRI scale of joint damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2002.00694.X

10.1046/J.1365-2516.2002.00694.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12410643 AND SRC:MED&resulttype=core&format=json

14 December 2019

1 reference